This Board sure gets quiet when the pps goes up???
Amazing how the frame of reference for "going up" always seems to go down...
On 1/27/05 Peregrine received FDA approval to go ahead with a phase I anti-cancer trial for the then named Tarvacin.
On that day the stock closed at a split-adjusted price of $6.00 and had a similarly adjusted 29,786,200 shares outstanding.
And here we are, almost 5 years and an R/S later and what do we have to show for it?
A stock that closed "up" today at $2.85 and around 47MM shares outstanding.
Yep, that's progress...
Regards,
moby